Article Listing - Abbott Labs plans cost-cutting, 3,000 job losses as a result of Solvay integration

NASAL ASPIRIN

25 May 1992

- Researchers at the University of Kentucky have developed an asprin solution to be administered via a nasal spray. The...

APPOINTMENTS AT OTSUKA

25 May 1992

- Appointments at Otsuka: Tamotsu Fujino becomes vice director, liaison with licensors, at the Tokyo office of corporate planning; Jun'ichi...

IMMUNE RESPONSE AND R-PR: AIDS INVESTMENT

25 May 1992

- Immune Response Corp and Rhone-Poulenc Rorer have agreed a further investment of $9 million each in their joint AIDS...

LOSEC SALES ROCKET FOR ASTRA

25 May 1992

Reporting first-quarter 1992 turn-over up 35% at 3.7 billion Swed-ish kroner, Sweden's Astra AB notes that sales of its proton...

UK BIOTECH COS PLAN FLOTATIONS

25 May 1992

Two of the UK's largest biotechnol-ogy concerns, Celltech and British Biotechnology, have plans to float their companies on the stock...

FDA PANEL'S POSITIVE REVIEW ON HALCION

25 May 1992

Following the US Food and Drug Administration's Psychopharmacol-ogical Drug Products Advisory Committee's conclusion that Upjohn's Halcion (triazolam) is safe and...

US BIOTECH COS NEED GOVT SUPPORT

25 May 1992

Unless concrete steps are taken by the government, industries and universities to ensure that there is a two-way exchange of...

SYNTHELABO INTENDS TO UP INTERNATIONAL STATUS

25 May 1992

At Synthelabo's first meeting with analysts, the company reviewed 1991 results, set out the rationale behind recent acquisitions and discussed...

PROSPECTS FOR THE OTC MARKET IN ISRAEL

25 May 1992

Traditionally, the over-the-counter medicines market in Israel has not been of any significant size, but there have in recent times...

BAYER ESPANA'S 1991 PROFITS DOWN 21.4%

25 May 1992

Bayer Espana, Spanish subsidiary of the German pharmaceutical group, Bayer, made consolidated pretax profits of 8.9 billion pesetas ($86 million)...

Showing 94031-94040 of 95569 articles